# Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery

> **NCT03038373** · — · UNKNOWN · sponsor: **Dasman Diabetes Institute** · enrollment: 80 (estimated)

## Conditions studied

- Morbid Obesity
- Type2 Diabetes

## Interventions

- **PROCEDURE:** Laparoscopic Sleeve Gastrectomy

## Key facts

- **NCT ID:** NCT03038373
- **Lead sponsor:** Dasman Diabetes Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2022-06
- **Final completion:** 2024-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038373, "Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03038373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*